What changed 10-Q

Item 2. Unregistered Sales of Equity Securities

2023-05-02 compared with 2022-11-01 · 1 added, 4 removed, 6 unchanged (45% of the section changed)

1 unchanged sentence

Sale of Unregistered Securities.

On July 1, 2022, the Company issued 34,899 shares of its common stock, $0.00025 par value per share, in connection with the purchase of all of the issued and outstanding shares of Pega Medical Inc.

The purchase price also included $32.0 million in cash.

The shares were valued at $42.90 per share on the date of issuance.

The issuance of the common stock was made in reliance upon an exemption provided under Section 4(a)(2) of the Securities Act of 1933, as amended.

None, except as otherwise described in a Current Report on Form 8-K filed with respect to the period covered by this Quarterly Report on Form 10-Q.

Use of Proceeds.

3 unchanged sentences

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.